Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Cancer, Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00205322
What this trial is testing

Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University of Wisconsin, Madison 45
Large-scale testing (Phase 3)Study completedNCT00154102
What this trial is testing

Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)

Who this might be right for
Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
Merck KGaA, Darmstadt, Germany 1,221
Not applicableStudy completedNCT05420870
What this trial is testing

Effect of Exercise on Bowel Function in Colorectal Cancer Survivors

Who this might be right for
Colorectal CancerLow Anterior Resection Syndrome
Yonsei University 50
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Ended earlyNCT02102022
What this trial is testing

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Who this might be right for
Advanced Gastrointestinal (GI) MalignanciesHepatocellular CarcinomaGastric Cancer+1 more
Polaris Group 140
Testing effectiveness (Phase 2)Study completedNCT00111761
What this trial is testing

Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Amgen 43
Early research (Phase 1)Study completedNCT02416466
What this trial is testing

CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases

Who this might be right for
Liver Metastases
Roger Williams Medical Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT07805551
What this trial is testing

HDM2017 Combination Therapy in Advanced Colorectal Cancer

Who this might be right for
CRC, Colorectal Cancer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 220
Not applicableEnded earlyNCT01137162
What this trial is testing

Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors

Who this might be right for
Anal, Colon, and Rectal CancersHead and Neck CancerLung Cancer+17 more
Stanford University 10
Large-scale testing (Phase 3)UnknownNCT04233151
What this trial is testing

QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 590
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableLooking for participantsNCT06896162
What this trial is testing

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Who this might be right for
Solid Tumor MalignanciesMetastatic CancerBreast Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 500
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Not applicableActive Not RecruitingNCT04157322
What this trial is testing

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

Who this might be right for
Colorectal Cancer Stage IVColorectal Cancer MetastaticColorectal Cancer, Genetics of+1 more
University of Chicago 55
Large-scale testing (Phase 3)Study completedNCT01072851
What this trial is testing

Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print

Who this might be right for
Colorectal Cancer
Trinity Health Of New England 920
Testing effectiveness (Phase 2)Study completedNCT03735680
What this trial is testing

Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaColorectal Cancer+4 more
OncoNano Medicine, Inc. 30
Post-approval studies (Phase 4)Ended earlyNCT00129870
What this trial is testing

CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sanofi 180
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Not applicableStudy completedNCT01346280
What this trial is testing

Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs

Who this might be right for
Non-Small Cell Lung Cancer (Stage III)Colon Cancer (Stage II &Amp; III)Rectal Cancer (Stage III)
National Cancer Institute (NCI) 1,079
Not applicableStudy completedNCT01804179
What this trial is testing

Colorectal Cancer Awareness, Research, Education and Screening (CARES)

Who this might be right for
Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute 514
Next Page